PMID- 29080221
OWN - NLM
STAT- MEDLINE
DCOM- 20180125
LR  - 20180125
IS  - 1527-3350 (Electronic)
IS  - 0270-9139 (Linking)
VI  - 67
IP  - 1
DP  - 2018 Jan
TI  - Hepatitis B reactivation in chronic hepatitis C patients treated with interferon 
      or pan-oral direct-acting antivirals.
PG  - 453-454
LID - 10.1002/hep.29620 [doi]
FAU - Liu, Jiaye
AU  - Liu J
AD  - Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, 
      Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
AD  - Academy of Preventive Medicine, Shandong University, Jinan, China.
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - Hepatology
JT  - Hepatology (Baltimore, Md.)
JID - 8302946
RN  - 0 (Antiviral Agents)
RN  - 9008-11-1 (Interferons)
SB  - IM
CON - Hepatology. 2017 Jul;66(1):13-26. PMID: 28195337
CIN - Hepatology. 2018 Jan;67(1):454-455. PMID: 29080218
MH  - Antiviral Agents
MH  - Hepatitis B
MH  - *Hepatitis C, Chronic
MH  - Humans
MH  - *Interferons
EDAT- 2017/10/29 06:00
MHDA- 2018/01/26 06:00
CRDT- 2017/10/29 06:00
PHST- 2017/05/16 00:00 [received]
PHST- 2017/07/09 00:00 [revised]
PHST- 2017/08/01 00:00 [accepted]
PHST- 2017/10/29 06:00 [pubmed]
PHST- 2018/01/26 06:00 [medline]
PHST- 2017/10/29 06:00 [entrez]
AID - 10.1002/hep.29620 [doi]
PST - ppublish
SO  - Hepatology. 2018 Jan;67(1):453-454. doi: 10.1002/hep.29620.